Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
New VLA Virology Facility to Benefit Exotic Disease Research
Inside one of the high containment laboratories
The Veterinary Laboratories Agency has officially opened its new high containment virus research facility.

With state-of-the-art technologies and an innovative modular design for secure biocontainment, the laboratory will be the hub of a diverse range of research activities.

Viral diseases, such as influenza and rabies, which continue to be a threat to man, livestock, companion animals and wildlife will be studied and particularly those whose importance has escalated through climate change.

The laboratory has specialist facilities to maintain insect colonies so VLA scientists can study their potential to act as vectors. This will support research on diseases transmitted by insect vectors which are seen as an increased risk especially due to climate change. Examples include West Nile fever virus, Japanese encephalitis virus and tick-borne encephalitis.

The building will also house VLA’s virus repository for avian influenza, Newcastle disease, rabies and other exotic viruses as well as providing an enhanced capability for maintaining virus archives supported by the European Virus Archive (EVA) project.

Prof. Peter Borriello opening the new facility
At the official opening, Peter Borriello, VLA’s Chief Executive, said: “This new facility will enable VLA to continue to maintain a cost efficient, high profile strategic programme of work for animal and human health, benefiting the public, farmers and the government. The laboratory will provide valuable support to our unique specialist service in research, surveillance and emergency response to disease outbreaks.”

The new facility will also underpin VLA’s essential reference laboratory activities.  It will provide further opportunities for developing its academic partnerships with UK universities as well as leading a number research projects with international networks such as CIDLID, ArboZooNet, FluTrain and Offlu.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'